Cargando…

Prognostic value of circulating chromogranin A levels in acute coronary syndromes

AIMS: To determine whether circulating levels of chromogranin A (CgA) provide prognostic information independently of conventional risk markers in acute coronary syndromes (ACSs). METHODS AND RESULTS: We measured circulating CgA levels on day 1 in 1268 patients (median age 67 years, 70% male) with A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jansson, Anna M., Røsjø, Helge, Omland, Torbjørn, Karlsson, Thomas, Hartford, Marianne, Flyvbjerg, Allan, Caidahl, Kenneth
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639087/ https://www.ncbi.nlm.nih.gov/pubmed/19028779 http://dx.doi.org/10.1093/eurheartj/ehn513

Ejemplares similares

Prognostic value of circulating chromogranin A levels in acute coronary syndrome: reply
por: Røsjø, Helge, et al.
Publicado: (2010)

Long-term prognostic value of mitral regurgitation in acute coronary syndromes
por: Persson, Anita, et al.
Publicado: (2010)

The association between circulating adiponectin levels, lung function and adiposity in subjects from the general population; data from the Akershus Sleep Apnea Project
por: Caspersen, Nina F., et al.
Publicado: (2018)

Prognostic Value of Circulating MicroRNA-210 Levels in Patients with Moderate to Severe Aortic Stenosis
por: Røsjø, Helge, et al.
Publicado: (2014)

Prognostic value of high-sensitivity troponin T levels in patients with ventricular arrhythmias and out-of-hospital cardiac arrest: data from the prospective FINNRESUSCI study
por: Røsjø, Helge, et al.
Publicado: (2014)

Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome
por: Røsjø, Helge, et al.
Publicado: (2010)

Circulating MicroRNAs and Aerobic Fitness – The HUNT-Study
por: Bye, Anja, et al.
Publicado: (2013)

Prognostic value of cardiac biomarkers and National Early Warning Score 2 in acute dyspnoea
por: Berge, Kristian, et al.
Publicado: (2022)

Associations between circulating microRNAs and lipid-rich coronary plaques measured with near-infrared spectroscopy
por: Sæther, Julie Caroline, et al.
Publicado: (2023)

Subclinical Myocardial Injury and Risk of COVID-19 in the General Population: The Trøndelag Health Study
por: Lyngbakken, Magnus Nakrem, et al.
Publicado: (2021)

Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study
por: Røysland, Ragnhild, et al.
Publicado: (2012)

Altered Chromogranin A Circulating Levels in Meniere's Disease
por: Teggi, Roberto, et al.
Publicado: (2015)

Tobacco Consumption and High‐Sensitivity Cardiac Troponin I in the General Population: The HUNT Study
por: Skranes, Julia Brox, et al.
Publicado: (2022)

N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: a prospective observational study
por: Aarsetøy, Reidun, et al.
Publicado: (2020)

Established Cardiovascular Biomarkers Provide Limited Prognostic Information in Unselected Patients Hospitalized With COVID-19
por: Omland, Torbjørn, et al.
Publicado: (2020)

Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study
por: Røysland, Ragnhild, et al.
Publicado: (2016)

Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine
por: Fuksiewicz, Małgorzata, et al.
Publicado: (2018)

Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study
por: Winther, Jacob A., et al.
Publicado: (2017)

Characterisation of circulating chromogranin A in human cancer patients.
por: Corti, A., et al.
Publicado: (1996)

Diagnostic Value of Circulating Chromogranin A for Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
por: Yang, Xin, et al.
Publicado: (2015)

Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties
por: Røsjø, Helge, et al.
Publicado: (2012)

Regulation of tumor growth by circulating full-length chromogranin A
por: Curnis, Flavio, et al.
Publicado: (2016)

Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
por: Gulati, Geeta, et al.
Publicado: (2017)

Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes
por: Røysland, Ragnhild, et al.
Publicado: (2012)

Serum chromogranin A levels are associated with the SYNTAX score in coronary artery disease
por: Çelikkol, Aliye, et al.
Publicado: (2023)

Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study
por: Winther, Jacob A., et al.
Publicado: (2016)

Prognostic impact of chromogranin A in patients with acute heart failure
por: Kim, Hong Nyun, et al.
Publicado: (2021)

Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19
por: Myhre, Peder L., et al.
Publicado: (2020)

Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers
por: Gaiser, Maria Rita, et al.
Publicado: (2015)

Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2020)

QRS fragmentation is associated with increased risk of ventricular arrhythmias in high‐risk patients; Data from the SMASH 1 Study
por: Sourour, Nur, et al.
Publicado: (2022)

Low Efficacy of Chromogranin A Elimination by Therapeutic Plasma Exchange for Treatment of Chromogranin A Tubulopathy
por: Hakroush, Samy, et al.
Publicado: (2021)

Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity
por: Myhre, Peder L., et al.
Publicado: (2021)

The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease
por: Watanabe, Takuya
Publicado: (2021)

Chromogranin A, a significant prognostic factor in small cell lung cancer
por: Drivsholm, L, et al.
Publicado: (1999)

Chromogranin A Tubulopathy: Differing Histopathologic Patterns of Acute Tubular Injury in the Setting of Neuroendocrine Neoplasms
por: Sekulic, Miroslav, et al.
Publicado: (2019)

Elevated serum levels of Chromogranin A in hepatocellular carcinoma
por: Biondi, Antonio, et al.
Publicado: (2012)

N‐terminal pro‐B‐type natriuretic peptide for prediction of ventricular arrhythmias: Data from the SMASH study
por: Sourour, N., et al.
Publicado: (2023)

Associations between cardiovascular risk factors, biomarkers, and left ventricular mechanical dispersion: insights from the ACE 1950 Study
por: Aagaard, Erika N, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5r3ihdpp1j4vegpos364ovnnim